Parkman Healthcare Partners’s InfuSystem Holdings INFU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-251,567
Closed -$5.23M 78
2021
Q2
$5.23M Sell
251,567
-27,266
-10% -$551K 1.14% 33
2021
Q1
$5.68M Buy
278,833
+37,322
+15% +$699K 1.32% 26
2020
Q4
$4.54M Buy
241,511
+8,576
+4% +$129K 1.16% 34
2020
Q3
$2.99M Buy
232,935
+17,452
+8% +$227K 0.79% 44
2020
Q2
$2.49M Buy
215,483
+45,000
+26% +$517K 0.7% 48
2020
Q1
$1.45M Buy
170,483
+45,483
+36% +$411K 0.67% 47
2019
Q4
$1.07M Buy
+125,000
New +$920K 0.31% 63

Other funds holding INFU

Parkman Healthcare Partners's INFU Position: Q3 2021 in Review

Parkman Healthcare Partners sold out of InfuSystem Holdings (INFU) in Q3 2021, closing a stake of 251,567 shares — an estimated $5.23M sold.

Parkman Healthcare Partners first reported a position in INFU in Q4 2019 and held it in 7 quarters. The position peaked at $5.68M in Q1 2021. 82 funds tracked by Wall St. Rank hold INFU as of Q3 2021.

  • Parkman Healthcare Partners reported no remaining InfuSystem Holdings position as of Q3 2021 after selling out during the quarter.
  • Parkman Healthcare Partners sold 251,567 InfuSystem Holdings shares in Q3 2021, an estimated $5.23M.
  • Parkman Healthcare Partners first reported a position in InfuSystem Holdings in Q4 2019 and held it in 7 quarters.
  • Parkman Healthcare Partners's InfuSystem Holdings position peaked at $5.68M in Q1 2021.
  • 82 funds tracked by Wall St. Rank held InfuSystem Holdings as of Q3 2021.

Based on Parkman Healthcare Partners's 13F filing for Q3 2021, filed 12 Nov 2021.